Dr. Gregory Paul Morgan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 81 Northside Dawson Dr Ste 205, Dawsonville, GA 30534 Phone: 706-265-1335 |
Saba Haeringer, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 81 Northside Dawson Dr Ste 205, Dawsonville, GA 30534 Phone: 706-265-1335 |
Hema Byrapuneni, MEDICAL DOCTOR Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 133 Prominence Ct, Ste 230, Dawsonville, GA 30534 Phone: 706-216-1500 Fax: 706-216-1510 |
News Archive
U.S. News & World Report examines government data from more than 15,500 nursing homes to determine which are the nation's best: "At the core of the rankings is the data and ratings found on Nursing Home Compare, a federal website created by the Centers for Medicare and Medicaid Services.
Discovery Laboratories, Inc., a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010.
Two UNC School of Medicine faculty authored an editorial in the July 15, 2010 New England Journal of Medicine commenting on results from two clinical trials using the drug Rituximab to treat small-vessel vasculitis, a rare autoimmune disease.
New research reveals that the greatest demand for liver transplantation due to hepatitis C (HCV)-related liver disease occurs among Americans born between 1941 and 1960. Findings in the December issue of Liver Transplantation, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases (AASLD), suggest that continuing increased demand for transplantation is driven by the development of liver cancer in baby boomers with HCV, but that the demand may decrease as patients born in this time period continue to grow older.
ArtVentive Medical Group, Inc. announced today that the Company has frozen its Endoluminal Occlusion device design for the peripheral category of indications in preparation for the Company's regulatory phase, prior to commercialization in Europe and North America and subsequent to venturing forward into Eastern Europe, Japan, Asia Pacific and Latin America.
› Verified 2 days ago